Dev Labtech Venture Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 27, 2025, 2:10 pm

Market Cap	92.1 Cr.
Current Price	77.6
High / Low	104/52.0
Stock P/E	71.4
Book Value	36.4
Dividend Yield	0.00 %
ROCE	5.70 %
ROE	3.85 %
Face Value	10.0
PEG Ratio	-7.28

Quick Insight

Hindustan Unilever Ltd, trading at ₹74.2 with a market capitalization of ₹88.1 crore, presents a mixed investment case. The company's P/E ratio of 68.3 indicates a high valuation, suggesting that investors are paying a premium for future growth. However, with a return on equity (ROE) of only 3.85% and a return on capital employed (ROCE) of 5.70%, the firm’s profitability metrics are concerning, particularly given its operating profit margin (OPM) of 23%. The substantial reserves of ₹49,167 crore and manageable borrowings of ₹1,648 crore suggest financial stability. Nonetheless, with a price-to-book value (P/BV) of 60.32x, the stock appears overvalued. Investors should approach with caution, weighing the high valuation against the company's sluggish profitability metrics.

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Dev Labtech Venture Ltd

Competitors of Dev Labtech Venture Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Gujarat Metallic Coal & Coke Ltd	5.94 Cr.	30.0	/		77.6	0.00 %	0.37 %	2.00 %	100
Gensol Engineering Ltd	185 Cr.	48.7	1,050/38.4	2.14	155	0.00 %	14.3 %	20.1 %	10.0
Gagan Polycot India Ltd	0.86 Cr.	0.86	/		4.08	0.00 %	81.2 %	81.2 %	10.0
Fusion Micro Finance Ltd	2,520 Cr.	183	436/124		101	0.00 %	2.96 %	54.5 %	10.0
Five X Tradecom Ltd	0.99 Cr.	0.48	/		9.35	0.00 %	0.00 %	0.00 %	10.0
Industry Average	6,790.76 Cr	265.80		426.29	93.23	0.26%	13.53%	63.44%	9.22

All Competitor Stocks of Dev Labtech Venture Ltd

Quarterly Result

Metric	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025
Sales	19.43	9.66	20.68	20.92	22.30	19.51	32.90
Expenses	18.99	8.64	19.80	18.82	21.53	18.30	31.03
Operating Profit	0.44	1.02	0.88	2.10	0.77	1.21	1.87
OPM %	2.26%	10.56%	4.26%	10.04%	3.45%	6.20%	5.68%
Other Income	0.11	0.16	0.00	0.01	0.00	0.00	0.00
Interest	0.06	0.05	0.05	0.07	0.05	0.05	0.07
Depreciation	0.04	0.27	0.29	0.46	0.47	0.50	0.61
Profit before tax	0.45	0.86	0.54	1.58	0.25	0.66	1.19
Tax %	15.56%	34.88%	18.52%	17.09%	88.00%	25.76%	31.93%
Net Profit	0.37	0.57	0.45	1.31	0.03	0.48	0.81
EPS in Rs	2.94	1.17	0.54	1.58	0.04	0.46	0.72

Last Updated: May 31, 2025, 6:19 am

Below is a detailed analysis of the quarterly data for Dev Labtech Venture Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 32.90 Cr.. The value appears strong and on an upward trend. It has increased from 19.51 Cr. (Sep 2024) to 32.90 Cr., marking an increase of 13.39 Cr..
For Expenses, as of Mar 2025, the value is 31.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.30 Cr. (Sep 2024) to 31.03 Cr., marking an increase of 12.73 Cr..
For Operating Profit, as of Mar 2025, the value is 1.87 Cr.. The value appears strong and on an upward trend. It has increased from 1.21 Cr. (Sep 2024) to 1.87 Cr., marking an increase of 0.66 Cr..
For OPM %, as of Mar 2025, the value is 5.68%. The value appears to be declining and may need further review. It has decreased from 6.20% (Sep 2024) to 5.68%, marking a decrease of 0.52%.
For Other Income, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Interest, as of Mar 2025, the value is 0.07 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.05 Cr. (Sep 2024) to 0.07 Cr., marking an increase of 0.02 Cr..
For Depreciation, as of Mar 2025, the value is 0.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.50 Cr. (Sep 2024) to 0.61 Cr., marking an increase of 0.11 Cr..
For Profit before tax, as of Mar 2025, the value is 1.19 Cr.. The value appears strong and on an upward trend. It has increased from 0.66 Cr. (Sep 2024) to 1.19 Cr., marking an increase of 0.53 Cr..
For Tax %, as of Mar 2025, the value is 31.93%. The value appears to be increasing, which may not be favorable. It has increased from 25.76% (Sep 2024) to 31.93%, marking an increase of 6.17%.
For Net Profit, as of Mar 2025, the value is 0.81 Cr.. The value appears strong and on an upward trend. It has increased from 0.48 Cr. (Sep 2024) to 0.81 Cr., marking an increase of 0.33 Cr..
For EPS in Rs, as of Mar 2025, the value is 0.72. The value appears strong and on an upward trend. It has increased from 0.46 (Sep 2024) to 0.72, marking an increase of 0.26.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:10 pm

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	11.79	12.24	26.98	30.34	43.22	52.41
Expenses	11.41	11.96	26.28	28.43	40.35	49.33
Operating Profit	0.38	0.28	0.70	1.91	2.87	3.08
OPM %	3.22%	2.29%	2.59%	6.30%	6.64%	5.88%
Other Income	-0.00	0.04	0.12	0.16	0.01	-0.00
Interest	0.18	0.16	0.14	0.10	0.12	0.12
Depreciation	0.15	0.11	0.09	0.55	0.93	1.11
Profit before tax	0.05	0.05	0.59	1.42	1.83	1.85
Tax %	100.00%	40.00%	16.95%	27.46%	26.78%	29.73%
Net Profit	-0.00	0.04	0.49	1.02	1.34	1.29
EPS in Rs	-0.00	1.91	3.90	1.23	1.62	1.14
Dividend Payout %		-0.00%	-0.00%	-0.00%	-0.00%	-0.00%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	1125.00%	108.16%	31.37%	-3.73%
Change in YoY Net Profit Growth (%)	0.00%	-1016.84%	-76.79%	-35.10%

Dev Labtech Venture Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	35%
3 Years:	25%
TTM:	21%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	48%
TTM:	-4%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	-18%

Return on Equity
10 Years:	%
5 Years:	6%
3 Years:	5%
Last Year:	4%

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:27 pm

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	0.21	0.21	1.26	8.27	8.27	11.30
Reserves	1.24	1.28	0.77	10.61	17.51	29.87
Borrowings	1.54	1.78	1.23	1.13	1.10	1.02
Other Liabilities	4.13	3.87	5.68	3.72	1.78	1.59
Total Liabilities	7.12	7.14	8.94	23.73	28.66	43.78
Fixed Assets	0.81	0.71	0.37	4.15	5.01	4.89
CWIP	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	6.31	6.43	8.57	19.58	23.65	38.89
Total Assets	7.12	7.14	8.94	23.73	28.66	43.78

Below is a detailed analysis of the balance sheet data for Dev Labtech Venture Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 11.30 Cr.. The value appears strong and on an upward trend. It has increased from 8.27 Cr. (Mar 2024) to 11.30 Cr., marking an increase of 3.03 Cr..
For Reserves, as of Mar 2025, the value is 29.87 Cr.. The value appears strong and on an upward trend. It has increased from 17.51 Cr. (Mar 2024) to 29.87 Cr., marking an increase of 12.36 Cr..
For Borrowings, as of Mar 2025, the value is 1.02 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1.10 Cr. (Mar 2024) to 1.02 Cr., marking a decrease of 0.08 Cr..
For Other Liabilities, as of Mar 2025, the value is 1.59 Cr.. The value appears to be improving (decreasing). It has decreased from 1.78 Cr. (Mar 2024) to 1.59 Cr., marking a decrease of 0.19 Cr..
For Total Liabilities, as of Mar 2025, the value is 43.78 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.66 Cr. (Mar 2024) to 43.78 Cr., marking an increase of 15.12 Cr..
For Fixed Assets, as of Mar 2025, the value is 4.89 Cr.. The value appears to be declining and may need further review. It has decreased from 5.01 Cr. (Mar 2024) to 4.89 Cr., marking a decrease of 0.12 Cr..
For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Mar 2025, the value is 38.89 Cr.. The value appears strong and on an upward trend. It has increased from 23.65 Cr. (Mar 2024) to 38.89 Cr., marking an increase of 15.24 Cr..
For Total Assets, as of Mar 2025, the value is 43.78 Cr.. The value appears strong and on an upward trend. It has increased from 28.66 Cr. (Mar 2024) to 43.78 Cr., marking an increase of 15.12 Cr..

Notably, the Reserves (29.87 Cr.) exceed the Borrowings (1.02 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Month		Mar 2020	Mar 2021	Mar 2022
Cash from Operating Activity +	0.30	-0.08	0.18	-5.72	-9.28
Cash from Investing Activity +	-0.02	-0.01	0.36	-4.17	-1.78
Cash from Financing Activity +	-0.26	0.08	-0.50	15.63	5.43
Net Cash Flow	0.02	-0.01	0.04	5.74	-5.63

Free Cash Flow

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-1.16	-1.50	-0.53	0.78	1.77	2.06

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	70.28	89.16	55.20	56.54	16.13
Inventory Days	191.01	123.38	48.27	122.84	208.18
Days Payable	192.65	160.22	85.88	33.95	5.37
Cash Conversion Cycle	68.63	52.32	17.58	145.43	218.94
Working Capital Days	57.89	67.99	34.36	120.30	184.10
ROCE %		6.71%	18.99%	11.69%	8.32%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Dec 2024	Jan 2025
Promoters	68.01%	68.01%	68.01%	54.58%	52.35%	54.55%
Public	31.99%	31.99%	32.00%	45.42%	47.65%	45.44%
No. of Shareholders	682	482	469	613	830	858

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund.

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	1.62	1.62	0.96	3.47	1.74
Diluted EPS (Rs.)	1.62	1.62	0.96	3.47	1.74
Cash EPS (Rs.)	2.13	2.75	1.90	4.16	6.84
Book Value[Excl.RevalReserv]/Share (Rs.)	36.42	31.16	22.83	15.28	70.86
Book Value[Incl.RevalReserv]/Share (Rs.)	36.42	31.16	22.83	15.28	70.86
Revenue From Operations / Share (Rs.)	46.37	52.26	36.68	213.58	584.18
PBDIT / Share (Rs.)	2.72	3.48	2.31	5.42	15.30
PBIT / Share (Rs.)	1.74	2.36	1.64	4.74	10.20
PBT / Share (Rs.)	1.63	2.21	1.70	3.63	2.61
Net Profit / Share (Rs.)	1.14	1.62	1.23	3.47	1.74
PBDIT Margin (%)	5.86	6.66	6.29	2.53	2.61
PBIT Margin (%)	3.75	4.50	4.46	2.21	1.74
PBT Margin (%)	3.52	4.23	4.64	1.69	0.44
Net Profit Margin (%)	2.46	3.10	3.35	1.62	0.29
Return on Networth / Equity (%)	3.14	5.20	5.39	22.71	2.45
Return on Capital Employeed (%)	4.63	7.22	6.77	19.08	7.35
Return On Assets (%)	2.95	4.67	4.29	4.91	0.51
Long Term Debt / Equity (X)	0.02	0.04	0.05	0.59	0.93
Total Debt / Equity (X)	0.02	0.04	0.05	0.63	1.20
Asset Turnover Ratio (%)	1.45	1.65	1.86	3.35	1.72
Current Ratio (X)	29.54	14.01	5.24	1.44	1.45
Quick Ratio (X)	5.02	2.28	3.18	0.90	0.77
Inventory Turnover Ratio (X)	2.09	0.16	0.83	8.34	1.03
Interest Coverage Ratio (X)	25.49	24.43	18.29	4.89	2.02
Interest Coverage Ratio (Post Tax) (X)	11.72	12.38	9.23	3.31	1.23
Enterprise Value (Cr.)	68.16	83.64	37.44	0.00	0.00
EV / Net Operating Revenue (X)	1.30	1.94	1.23	0.00	0.00
EV / EBITDA (X)	22.16	29.04	19.60	0.00	0.00
MarketCap / Net Operating Revenue (X)	1.28	1.91	1.39	0.00	0.00
Price / BV (X)	1.63	3.21	2.23	0.00	0.00
Price / Net Operating Revenue (X)	1.28	1.91	1.39	0.00	0.00
EarningsYield	0.01	0.01	0.02	0.00	0.00

After reviewing the key financial ratios for Dev Labtech Venture Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 25, the value is 1.62. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 1.62.
For Diluted EPS (Rs.), as of Mar 25, the value is 1.62. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 1.62.
For Cash EPS (Rs.), as of Mar 25, the value is 2.13. This value is below the healthy minimum of 3. It has decreased from 2.75 (Mar 24) to 2.13, marking a decrease of 0.62.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.42. It has increased from 31.16 (Mar 24) to 36.42, marking an increase of 5.26.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 36.42. It has increased from 31.16 (Mar 24) to 36.42, marking an increase of 5.26.
For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 46.37. It has decreased from 52.26 (Mar 24) to 46.37, marking a decrease of 5.89.
For PBDIT / Share (Rs.), as of Mar 25, the value is 2.72. This value is within the healthy range. It has decreased from 3.48 (Mar 24) to 2.72, marking a decrease of 0.76.
For PBIT / Share (Rs.), as of Mar 25, the value is 1.74. This value is within the healthy range. It has decreased from 2.36 (Mar 24) to 1.74, marking a decrease of 0.62.
For PBT / Share (Rs.), as of Mar 25, the value is 1.63. This value is within the healthy range. It has decreased from 2.21 (Mar 24) to 1.63, marking a decrease of 0.58.
For Net Profit / Share (Rs.), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 2. It has decreased from 1.62 (Mar 24) to 1.14, marking a decrease of 0.48.
For PBDIT Margin (%), as of Mar 25, the value is 5.86. This value is below the healthy minimum of 10. It has decreased from 6.66 (Mar 24) to 5.86, marking a decrease of 0.80.
For PBIT Margin (%), as of Mar 25, the value is 3.75. This value is below the healthy minimum of 10. It has decreased from 4.50 (Mar 24) to 3.75, marking a decrease of 0.75.
For PBT Margin (%), as of Mar 25, the value is 3.52. This value is below the healthy minimum of 10. It has decreased from 4.23 (Mar 24) to 3.52, marking a decrease of 0.71.
For Net Profit Margin (%), as of Mar 25, the value is 2.46. This value is below the healthy minimum of 5. It has decreased from 3.10 (Mar 24) to 2.46, marking a decrease of 0.64.
For Return on Networth / Equity (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 15. It has decreased from 5.20 (Mar 24) to 3.14, marking a decrease of 2.06.
For Return on Capital Employeed (%), as of Mar 25, the value is 4.63. This value is below the healthy minimum of 10. It has decreased from 7.22 (Mar 24) to 4.63, marking a decrease of 2.59.
For Return On Assets (%), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 5. It has decreased from 4.67 (Mar 24) to 2.95, marking a decrease of 1.72.
For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. It has decreased from 0.04 (Mar 24) to 0.02, marking a decrease of 0.02.
For Asset Turnover Ratio (%), as of Mar 25, the value is 1.45. It has decreased from 1.65 (Mar 24) to 1.45, marking a decrease of 0.20.
For Current Ratio (X), as of Mar 25, the value is 29.54. This value exceeds the healthy maximum of 3. It has increased from 14.01 (Mar 24) to 29.54, marking an increase of 15.53.
For Quick Ratio (X), as of Mar 25, the value is 5.02. This value exceeds the healthy maximum of 2. It has increased from 2.28 (Mar 24) to 5.02, marking an increase of 2.74.
For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.09. This value is below the healthy minimum of 4. It has increased from 0.16 (Mar 24) to 2.09, marking an increase of 1.93.
For Interest Coverage Ratio (X), as of Mar 25, the value is 25.49. This value is within the healthy range. It has increased from 24.43 (Mar 24) to 25.49, marking an increase of 1.06.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.72. This value is within the healthy range. It has decreased from 12.38 (Mar 24) to 11.72, marking a decrease of 0.66.
For Enterprise Value (Cr.), as of Mar 25, the value is 68.16. It has decreased from 83.64 (Mar 24) to 68.16, marking a decrease of 15.48.
For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.30. This value is within the healthy range. It has decreased from 1.94 (Mar 24) to 1.30, marking a decrease of 0.64.
For EV / EBITDA (X), as of Mar 25, the value is 22.16. This value exceeds the healthy maximum of 15. It has decreased from 29.04 (Mar 24) to 22.16, marking a decrease of 6.88.
For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.28. This value is within the healthy range. It has decreased from 1.91 (Mar 24) to 1.28, marking a decrease of 0.63.
For Price / BV (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has decreased from 3.21 (Mar 24) to 1.63, marking a decrease of 1.58.
For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.28. This value is within the healthy range. It has decreased from 1.91 (Mar 24) to 1.28, marking a decrease of 0.63.
For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Dev Labtech Venture Ltd as of July 27, 2025 is: 81.65

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of July 27, 2025, Dev Labtech Venture Ltd is Undervalued by 5.22% compared to the current share price 77.60

Intrinsic Value of Dev Labtech Venture Ltd as of July 27, 2025 is: 73.64

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of July 27, 2025, Dev Labtech Venture Ltd is Overvalued by 5.10% compared to the current share price 77.60

Last 5 Year EPS CAGR: -9.81%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (10.21 cr) compared to borrowings (1.30 cr), indicating strong financial stability. The company has shown consistent growth in sales (29.50 cr) and profit (0.97 cr) over the years.	The stock has a low average ROCE of 9.14%, which may not be favorable. The stock has a high average Working Capital Days of 92.93, which may not be favorable. The stock has a high average Cash Conversion Cycle of 100.58, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dev Labtech Venture Ltd:
1. Net Profit Margin: 2.46%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 4.63% (Industry Average ROCE: 12.72%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 3.14% (Industry Average ROE: 55.83%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 11.72
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 5.02
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 71.4 (Industry average Stock P/E: 272.82)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.02
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Dev Labtech Venture Ltd. is a Public Limited Listed company incorporated on 29/04/1993 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L36100GJ1993PLC019374 and registration number is 019374. Currently company belongs to the Industry of Gems, Jewellery & Precious Metals. Company's Total Operating Revenue is Rs. 52.41 Cr. and Equity Capital is Rs. 11.30 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Gems, Jewellery & Precious Metals	GF/22-23, Pattani Plaza, Bhavnagar Gujarat 364002	cs@devlabtechventure.com http://www.devlabtechventure.com

Management
Name	Position Held
Mr. Jerambhai Lavjibhai Donda	Chairman & Managing Director
Mr. Jay Jerambhai Donda	WholeTime Director & CFO
Mrs. Dimple Jay Donda	Non Executive Director
Mr. Vivekbhai Tulsibhai Mavani	Independent Director
Mr. Brijeshkumar Maheshbhai Pathak	Independent Director

FAQ

What is the intrinsic value of Dev Labtech Venture Ltd?

Dev Labtech Venture Ltd's intrinsic value (as of 27 July 2025) is 81.65 5.22% higher the current market price of 77.60, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 92.1 Cr. market cap, FY2025-2026 high/low of 104/52.0, reserves of 29.87 Cr, and liabilities of 43.78 Cr.

What is the Market Cap of Dev Labtech Venture Ltd?

The Market Cap of Dev Labtech Venture Ltd is 92.1 Cr..

What is the current Stock Price of Dev Labtech Venture Ltd as on 27 July 2025?

The current stock price of Dev Labtech Venture Ltd as on 27 July 2025 is 77.6.

What is the High / Low of Dev Labtech Venture Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Dev Labtech Venture Ltd stocks is ₹104/52.0.

What is the Stock P/E of Dev Labtech Venture Ltd?

The Stock P/E of Dev Labtech Venture Ltd is 71.4.

What is the Book Value of Dev Labtech Venture Ltd?

The Book Value of Dev Labtech Venture Ltd is 36.4.

What is the Dividend Yield of Dev Labtech Venture Ltd?

The Dividend Yield of Dev Labtech Venture Ltd is 0.00 %.

What is the ROCE of Dev Labtech Venture Ltd?

The ROCE of Dev Labtech Venture Ltd is 5.70 %.

What is the ROE of Dev Labtech Venture Ltd?

The ROE of Dev Labtech Venture Ltd is 3.85 %.

What is the Face Value of Dev Labtech Venture Ltd?

The Face Value of Dev Labtech Venture Ltd is 10.0.